StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report report published on Friday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 9.4 % BTX stock opened at $1.87 on Friday. The firm has a market cap of $110.00 million, a price-to-earnings ratio of […]